Richard Glickman

Richard Glickman

Chairman bei ESSA PHARMA INC.

Vermögen: 808 198 $ am 31.03.2024

65 Jahre
Health Technology
Finance
Commercial Services

Profil

Richard M.
Glickman
was the founder of Aurinia Pharmaceuticals, Inc. (founded in 1993) and Aspreva Pharmaceuticals Corp.
(founded in 2001), where he held the titles of Chairman & Chief Executive Officer.
Dr. Glickman was also the founder of Probtec Corp., Nventa Biopharmaceuticals Corp., Stressgen Biotechnologies Corp., Ontario Molecular Diagnostics, Aurinia Pharmaceuticals, Inc., and Aurinia Pharma Corp.Dr. Glickman's current job(s) included being the Chairman of ESSA Pharma, Inc. since 2010, a Director at MedGenesis Therapeutix, Inc., enGene, Inc., Eupraxia Pharmaceuticals, Inc., and Vida Pharmaceuticals Pvt Ltd., and an Independent Non-Executive Director at enGene Holdings, Inc. since 2023.
He is also a Director at Eurpraxia Pharmaceuticals, Inc. and a Venture Partner at Lumira Capital Investment Management, Inc.Dr. Glickman's former job(s) include being the Chairman of Vigil Health Solutions, Inc., LifeSciences British Columbia, and BC Biotech.
He also served as the Lead Independent Director at Correvio Pharma Corp., a Director at Canadian Genetic Disease Network and Vancouver Aquarium, and a Director at viDA Therapeutics, Inc. He was a Member of Innovate BC and a Venture Partner at Kearny Venture Partners.
Dr. Glickman's education history includes undergraduate studies at McGill University.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
01.11.2023 24 555 ( 0,06% ) 416 207 $ 31.03.2024
24.04.2024 43 240 ( 0,10% ) 367 108 $ 31.03.2024
18.08.2023 7 680 ( 0,03% ) 24 883 $ 31.03.2024

Aktive Positionen von Richard Glickman

UnternehmenPositionBeginn
ESSA PHARMA INC. Chairman 01.10.2010
EUPRAXIA PHARMACEUTICALS INC. Director/Board Member 09.03.2021
ENGENE HOLDINGS INC. Director/Board Member 24.04.2023
Private Equity Investor -
Vida Pharmaceuticals Pvt Ltd. Director/Board Member -
Director/Board Member -
Director/Board Member 23.09.2011
Alle aktiven Positionen von Richard Glickman

Ehemalige bekannte Positionen von Richard Glickman

UnternehmenPositionEnde
AURINIA PHARMACEUTICALS INC. Chief Executive Officer 29.04.2019
Chief Executive Officer 01.01.2019
░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░ ░░░░░ ░░░░░░░ -
Sehen Sie sich die Erfahrung von Richard Glickman im Detail an

Ausbildung von Richard Glickman

McGill University Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Richard Glickman im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

25

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen4
EUPRAXIA PHARMACEUTICALS INC.

Health Technology

ESSA PHARMA INC.

Health Technology

AURINIA PHARMACEUTICALS INC.

Health Technology

ENGENE HOLDINGS INC.

Health Technology

Private Unternehmen20

Health Technology

Health Technology

Health Technology

Electronic Technology

Health Technology

Health Technology

Finance

Stressgen Biotechnologies Corp. /Bioreagents Business/

Health Technology

Commercial Services

Health Technology

Canadian Genetic Disease Network

Finance

Commercial Services

Miscellaneous

Health Technology

Ontario Molecular Diagnostics

Probtec Corp.

Aurinia Pharmaceuticals, Inc. /Old/

Health Technology

Retail Trade

Vida Pharmaceuticals Pvt Ltd.

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Richard Glickman